“Agreement Between Patient and Physician Assessment of Eyebrow and Eyelash Hair Loss in Two Phase 3 Trials Evaluating Baricitinib in Patients with Severe Alopecia Areata” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s295. doi:10.25251/skin.7.supp.295.